The Effect of Family History on Insomnia During Sobriety in Alcoholics

Sponsor
Corporal Michael J. Crescenz VA Medical Center (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT01603381
Collaborator
(none)
22
1
2
49
0.4

Study Details

Study Description

Brief Summary

The investigators intend to assess the following:
  • the efficacy of CBTi in treating insomnia during recovery,

  • does a family history of alcoholism moderate the insomnia symptoms,

  • does an improvement in insomnia lead to a decrease in impulsivity.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I)
N/A

Detailed Description

The primary goals of this pilot study are the following:
  1. to assess for the difference in improvement insomnia, after 8 weeks of treatment with recommended CBTi, in Veterans with alcohol dependence during early recovery,
The secondary goals include the following:
  1. to assess for any change in the alcohol consumption indices between the groups after 8 weeks of CBTi,

  2. to assess for change in psychiatric symptoms of mood and anxiety across the groups,

  3. to assess for differences in insomnia in subjects, with and without a first degree family history of alcohol dependence,

  4. to evaluate for any change in impulsivity-related measure with insomnia treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
22 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Family History on Insomnia During Sobriety in Alcoholics
Study Start Date :
Jun 1, 2012
Actual Primary Completion Date :
Jul 1, 2016
Actual Study Completion Date :
Jul 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: CBT-I

Cognitive Behavioral Therapy for Insomnia

Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Behavioral management of insomnia

No Intervention: Monitor Only (M.O.)

Outcome Measures

Primary Outcome Measures

  1. Insomnia Severity Index total score [8 weeks.]

    There will be post-treatment follow up at 3 months and 6 months.

Secondary Outcome Measures

  1. Time Line Follow Back measure [8 weeks.]

    There will be post-study follow-up at 3 months and 6 months also.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Presence of insomnia currently

  2. DSM IV diagnosis of alcohol dependence within the past year

  3. Not in acute alcohol withdrawal and within a year of sobriety from alcoholism

  4. Patients with moderate-severe sleep apnea compliant on their PAP device

  5. Can speak, understand and print in English.

  6. Is capable of giving written informed consent.

Exclusion Criteria:
  1. Dependence on psychoactive substance (excluding alcohol, nicotine and cannabis) in the past 12 months, or evidence of chronic opiate use.

  2. Unstable/serious psychiatric condition e.g. schizophrenia, bipolar disorder.

  3. Unstable or serious medical/neurologic illness

  4. Severe cognitive impairment

  5. Untreated moderate - severe obstructive sleep apnea

Contacts and Locations

Locations

Site City State Country Postal Code
1 Philadelphia Veterans Affairs Medical Center Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • Corporal Michael J. Crescenz VA Medical Center

Investigators

  • Principal Investigator: Subhajit Chakravorty, M.D., Corporal Michael J. Crescenz VA Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Subhajit Chakravorty, Staff Physician, Corporal Michael J. Crescenz VA Medical Center
ClinicalTrials.gov Identifier:
NCT01603381
Other Study ID Numbers:
  • 01257
First Posted:
May 22, 2012
Last Update Posted:
Oct 4, 2016
Last Verified:
Oct 1, 2016
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 4, 2016